Medical practitioners are constantly updating and refining approaches to prostate cancer care, while new cutting-edge ...

By Dr Mihir Shanker, Radiation Oncologist, Icon Cancer CentreFor many men, a prostate cancer diagnosis raises understandable ...

Researchers have found in a large randomized trial that men with metastatic prostate cancer receiving androgen deprivation ...

An update in the New England Journal of Medicine has shown that transcatheter arterialization of the deep veins (TADV) using ...

Enzalutamide plus leuprolide reduces the risk of death by more than 40% in biochemically recurrent prostate cancer compared to leuprolide alone.

GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia in a ...

Boston Scientific (($BSX)) announced an update on their ongoing clinical study. Study Overview: Boston Scientific is conducting a study titled ...

MetroHealth launches safety net coverage help, LimFlow working to prevent amputations, a new menopause drug for hot flashes ...

Q3 2025 Earnings Call Transcript October 29, 2025 AxoGen, Inc. beats earnings expectations. Reported EPS is $0.12, ...

Cancer immunotherapy, especially using T cells, is showing a lot of promise in treating blood cancers. Bioengineered T cells, especially those equipped with chimeric antigen receptors (CAR-T cells), ...

The global oncology market is rapidly shifting toward smarter drug-delivery systems that enhance efficacy, reduce toxicity ...